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Lower tidal volumes (Vt);
Limits plateau pressure
(Pplat);
PredictorsAbstract Aim of the study: To identify outcome improvement factors in ARDS patients managed
with lung protective ventilation and deﬁned according to the Berlin diagnostic criteria.
Patients and methods: A retrospective observational study was conducted in a total of 41 ARDS
patients who were diagnosed according to the Berlin ARDS criteria. Demographic, clinical, labo-
ratory, and radiological criteria were assessed for all patients, and sputum, blood, and urine samples
were obtained on the ﬁrst day of hospitalization and on the day of ventilator-associated pneumonia
diagnosis. In addition, ﬂuid balance was assessed by the end of the ﬁrst week of ventilation. Signif-
icant factors associated with survival improvement and predictors of mortality were identiﬁed using
the bivariate analysis. ROC curves were created to evaluate the accuracy of some of the factors
affecting survival.
Results: In this study 25 variables were signiﬁcantly correlated with mortality. The non-surviving
patients had tachypnea and tachycardia; lower diastolic blood pressure, PaO2/FiO2, PO2, O2sat,
and HCO3 values; and higher FiO2 and PCO2 values. Additionally, they had lower serum Na
and higher K, pH, and creatinine levels. The level of CRP and GCS score were signiﬁcantly lower
in the non-surviving patients. However, the average ﬂuid balance in the non-surviving patients was
positive. Additionally, 4 non-surviving patients (33.3%) developed hospital-acquired pneumonia. A
996 A.M. Saleh et al.good general condition, indicated by a GCS score was the most accurate improvement prediction
factor, then proper oxygenation. In contrast, a delay in ICU admission, increase in serum creatinine
level, and a positive ﬂuid balance were accurate predictive factors of mortality.
Conclusions: Early diagnosis and ICU admission, a PaO2/FiO2 ratio maintained above 90, a
GCS score above 9, a negative ﬂuid balance, a serum creatinine level less than 1.5 mg/dl, and the
prevention of HAP were factors associated with an improved outcome in ARDS.
ª 2014 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V. Open access under CC BY-NC-ND license.Introduction
Worldwide, acute respiratory distress syndrome (ARDS) is
among the major causes of morbidity and mortality in
intensive care units (ICUs). The mortality rates in various
studies vary from 30% to 70%, even with optimal conven-
tional therapies [1,2]. Despite advances in our understanding
of the pathophysiology and treatment of ARDS, mortality
remains high; approximately 30–60% of patients die before
hospital discharge [3–5]. Lung protective ventilation, a strategy
that aims to achieve lower tidal volumes (Vt) and limits
plateau pressures (Pplat) to less than 30 cm H2O, was the only
clinical intervention that demonstrated a mortality beneﬁt in
large randomized trials [6].
Recently, the American–European conference and work-
shop revisited the deﬁnitions of acute lung injury and ARDS
and speciﬁcally re-evaluated the American–European consen-
sus conference deﬁnition from 1994. The result of this
workshop has been referred to as the Berlin deﬁnition of
ARDS. The authors recommended that patients be categorized
into three different classiﬁcations according to their PaO2/
FiO2 ratio: (A) mild ARDS, PaO2/FiO2 <300 but >200 mmHg;
(B) moderate ARDS, PaO2/FiO2 <200 but >100 mmHg; and
(C) severe ARDS, PaO2/FiO2 <100 mmHg. As expected, mor-
tality progressively declined in each of these groups. Using a
receiver operating curve, this revised deﬁnition yielded a small
but signiﬁcant improvement in the area under the curve from
0.53, derived from the American–European Consensus Confer-
ence (AECC) deﬁnition, to 0.57, although the absolute difference
is small [7].
Although ARDS is well studied worldwide, no local data
are available to document the factors associated with mortality
in ARDS and the outcome differences in patients with pul-
monary and extra-pulmonary ARDS. Early identiﬁcation of
these factors will aid in the assessment of prognosis, improve
treatment, and facilitate timely management. Furthermore,
to the best of our knowledge, no published studies on mortal-
ity predictors have been conducted in Saudi Arabia since the
implementation of a lung protective ventilation strategy. Thus,
we conducted a retrospective study of these variables to iden-
tify the early predictors of mortality in ARDS after the adop-
tion of a lung protective ventilation strategy and the use of the
new diagnostic criteria implemented based on the Berlin deﬁni-
tion of ARDS. We hypothesized that this ventilation strategy
would attenuate the predictive value of previously identiﬁed
pulmonary-speciﬁc measures.
Therefore, the aim of this study was to identify the factors
that affect survival and to detect the predictors of mortality in
ARDS patients managed with lung protective ventilation.Subjects and methods
Location
The study was conducted in the Adult Intensive Care Unit at
the Saudi German Hospital Al-Madinah, KSA.
Patients
A review of 41 medical records and physiological data was
completed for adult patients admitted to the Adult Intensive
Care Unit at the Saudi German Hospital Al-Madinah, KSA,
between 2012 and 2014. The patients met the diagnostic crite-
ria for ARDS according to the Berlin Deﬁnition 2012. These
criteria were as follows: (i) respiratory symptoms must have
begun within one week of a known clinical insult, or the
patient must have new or worsening symptoms during the past
week; (ii) bilateral opacities consistent with pulmonary edema
must be present on a chest radiograph or computed tomogra-
phy (CT) scan, and these opacities must not be fully explained
by pleural effusions, lobar collapse, lung collapse, or pulmon-
ary nodules; and (iii) the patient’s respiratory failure must not
be fully explained by cardiac failure or ﬂuid overload (an
objective assessment, e.g., echocardiography, to exclude
hydrostatic pulmonary edema is required if no risk factors
for ARDS are present); and (iv) moderate to severe impair-
ment of oxygenation must be present, as deﬁned by the ratio
of arterial oxygen tension to the fraction of inspired oxygen
(PaO2/FiO2). The severity of the hypoxemia deﬁnes the sever-
ity of the ARDS:
 Mild ARDS – a PaO2/FiO2 of >200 mmHg, but
6300 mmHg, with ventilator settings that include positive
end-expiratory pressure (PEEP) or continuous positive air-
way pressure (CPAP) P5 cm H2O.
 Moderate ARDS – a PaO2/FiO2 of >100 mmHg, but
6200 mmHg, with ventilator settings that include PEEP
P5 cm H2O.
 Severe ARDS – a PaO2/FiO2 of 6100 mmHg with ventila-
tor settings that include PEEP P5 cm H2O [7,8].
All patients had pulmonary ARDS. The primary causes
include the following: pneumonia, aspiration pneumonia,
inhalation injury, and lung contusions.
All patients with a history or clinical evidence of congestive
cardiac failure; patients with bronchogenic carcinoma, pul-
monary metastasis, or any neoplasm at ICU admission; or
patients who died within 24 h of ARDS diagnosis were
excluded from the study.
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This was a hospital record-based retrospective study of
patients with ARDS admitted to the Adult Intensive Care Unit
at the Saudi German Hospital Al-Madinah during the study
period.
Study tools
Data from the medical records and physiological data
obtained on the ﬁrst day of admission and throughout the
mechanical ventilation period, consisting of lung protective
ventilation strategy implementation as recommended by the
ARDS network, were collected from patients’ ﬁles.
These data include the following:
1. Demographic data, including age, gender, body mass index
(BMI), and smoking status;
2. Clinical data, including onset of illness; duration before
ICU admission; duration in ICU; clinical data relevant to
the chest, heart, and other body systems; and Glasgow
Coma Scale (GCS) score;
3. Gas exchange indicators, including FiO2, pH, PCO2, PO2,
O2sat, and HCO3;
4. PaO2/FiO2 ratio;
5. Laboratory assessments, including complete blood count
(CBC), blood gases, renal and liver function tests, erythro-
cyte sedimentation rate (ESR), and C-reactive protein
(CRP);
6. Independent radiologist scoring of the chest X-ray
appearance;
7. Sputum, blood, and urine samples obtained for sepsis work
up on the ﬁrst day of hospitalization and on the day of
ventilator-associated pneumonia (VAP) diagnosis;
8. Hemodynamic and ﬂuid balance data; and
9. Echocardiography assessments data.
This retrospective study was considered by the National
Research Ethics Service as a ‘service evaluation’. Therefore,
it did not require Research Ethics Committee review [9].
Statistical analysis
Data were analyzed using the Statistical Package for Social
Sciences (SPSS) version 19 (SPSS Inc., Chicago, IL, USA).
The ARDS surviving and non-surviving groups were com-
pared with respect to demographic criteria, clinical data, gas
exchange indicators, laboratory assessment data, radiological
data, and other possible factors affecting survival using the
chi-square test for qualitative variables and Student’s t-test
for quantitative variables. Receiver operating characteristic
(ROC) curves were created to evaluate the accuracy of some
of the factors affecting survival.
Results
A total of 41 moderate to severe ARDS patients diagnosed
according to the new classiﬁcation and the Berlin deﬁnitionwere
admitted to the ICU and managed with lung protective ventila-
tion. The overall mortality rate was 29.27%. Compared withpatients who survived, the non-surviving patients were older
( p< 0.001), included more smokers (p< 0.001), had more
prolonged durations of illness before ICU admission and more
prolonged ICU admission stay (p< 0.001), and had higher fre-
quencies of co-morbidities with DM (p< 0.001), hypertension
(p< 0.001), and cardiac problems (Table 1).
On admission to the ICU, the non-surviving patients had a
higher RR (p< 0.05) and HR (p< 0.05) and a lower DBP
(p< 0.001) compared with the patients who survived.
Additionally, compared with the patients who survived, the
non-surviving patients had lower PaO2/FiO2, PO2, O2sat,
and HCO3 values (p< 0.001 each) and higher FiO2 and
PCO2 values (p< 0.05). Additionally, they had lower Na lev-
els (p< 0.001) and higher K levels (p< 0.05), pH values
(p< 0.05), and creatinine levels (p< 0.001) compared with
the surviving patients. CRP and GCS were signiﬁcantly lower
in the non-surviving patients (p< 0.001). However, the
average weekly ﬂuid balance in the non-surviving patients
was positive and signiﬁcantly higher than that in the surviving
patients, who had negative ﬂuid balance (p< 0.001). Addi-
tionally, 4 non-surviving patients (33.3%) developed positive
blood Culture/sensitivity (C/S) and hospital-acquired pneumo-
nia (HAP), whereas none of the surviving patients developed
HAP. Other respiratory, hemodynamic, laboratory, and radio-
logical parameters were not signiﬁcantly different between the
two groups (Table 2).
The serum creatinine level showed the highest accuracy in
predicting non-survival (95.8%), with a sensitivity and speciﬁc-
ity of 100% and 93.1%, respectively, at a cutoff point of
1.15 mg%, followed by ﬂuid balance/week (90.7% accuracy,
91.70% sensitivity, and 93.10% speciﬁcity at a cutoff point
of 2694.63 ml) and duration of illness before ICU admission
(89.4% accuracy, 100% sensitivity, and 82.8% speciﬁcity at
a cutoff point of 6.5 days). In contrast, GCS showed the high-
est accuracy in predicting survival (97.6%), with a sensitivity
and speciﬁcity of 93.7% and 100%, respectively, at a cutoff
point of 9, followed by the PaO2/FiO2 ratio (85.3% accuracy,
93.1% sensitivity, and 83.3% speciﬁcity at a cutoff level of
90.08; Table 3 and Figs. 1 and 2).
Discussion
In this study, we sought to determine the factors that improve
outcomes in the treatment of ARDS in the new era of lung
protective ventilation after application of the two main
important factors that improve survival: low tidal volume
and plateau pressure. After application of the Berlin deﬁnition
of ARDS, we sought to determine the factors associated with
mortality on the ﬁrst day of admission and during the course
of treatment.
In our study of 41 patients, the mortality rate was approx-
imately 29%. Over the past two decades, there have been
studies from the world’s best medical centers claiming that
mortality has decreased by up to 30% [10,11], which may be
a result of improvement in the speciﬁc management of patients
with ARDS as well as in the general management of ICU
patients. However, in this same era of lung protective ventila-
tor strategy implementation, other studies [12,1] still report
mortality rates of 58%.
Other studies over the past 20 years have reported that
mortality from ALI/ARDS has decreased [13,14], and the only
Table 1 Clinical characteristics of patients on the ﬁrst day of ARDS.
Total (n= 41) Survivors (n= 29) Non survivors (n= 12) p value
Age 45.01 ± 17.14 35.90 ± 9.19 67.33 ± 9.54 <0.001**
Gender (male %) 33 (80.50%) 21 (72.40%) 12 (100.00%) >0.05
BMI 32.36 ± 5.48 32.16 ± 3.46 32.83 ± 8.84 >0.05
Smoking (smokers %) 9 (22.00%) 2 (6.90%) 7 (58.3%) <0.001**
Duration of illness before ICU admission (days) 6.87 ± 3.95 5.41 ± 3.35 10.41 ± 2.97 <0.001**
Duration of ICU stay (days) 27.61 ± 9.26 25.55 ± 5.552 32.58 ± 13.98 <0.05*
Co-morbidities
DM 11 (26.8%) 2 (6.9%) 9 (75.0%) <0.001**
Hypertension 8 (19.5%) 0 (0.0%) 8 (66.7%) <0.001**
Cardiac problems 3 (7.3%) 0 (0.0%) 3 (25.0%) <0.05*
Liver cirrhosis 1 (2.4%) 0 (0.0%) 1 (8.3%) –





Table 2 Clinical characteristics of patients on the ﬁrst day of ARDS.
Total (n= 41) Survivors (n= 29) Non survivors (n= 12) p value
Vital signs
RR 32.76 ± 4.06 31.62 ± 3.65 35.50 ± 3.80 <0.05*
HR 103.22 ± 14.40 100.21 ± 15.86 110.50 ± 5.65 <0.05*
SBP 122.85 ± 19.02 125.07 ± 21.33 117.50 ± 10.68 >0.05
DBP 75.44 ± 13.31 79.69 ± 11.58 65.17 ± 11.82 <0.001**
Gas exchange indicators
PaO2/FiO2 110.04 ± 32.33 121.62 ± 25.69 82.04 ± 30.20 <0.001
*
FiO2 0.64 ± 0.17 0.58 ± 0.08 0.79 ± 0.22 <0.05
*
PH 7.41 ± 0.08 7.43 ± 0.08 7.35 ± 0.05 <0.001**
PCO2 38.13 ± 5.92 37.15 ± 5.41 40.52 ± 6.65 >0.05
*
PO2 65.77 ± 9.25 68.54 ± 9.55 59.08 ± 3.14 <0.001
**
O2sat 91.34 ± 4.18 93.36 ± 2.80 86.47 ± 2.60 <0.001
**
HCO3 24.95 ± 5.01 26.63 ± 5.02 20.90 ± 1.27 <0.001
**
Laboratory ﬁndings
Na 137.90 ± 4.97 139.52 ± 4.49 134.00 ± 3.88 <0.001**
K 4.45 ± 0.87 4.20 ± 0.87 5.05 ± 0.50 <0.05*
Ca 8.40 ± 0.94 8.47 ± 1.09 8.21 ± 0.41 >0.05
Ph 2.93 ± 0.73 2.68 ± 0.40 3.55 ± 0.98 <0.05*
Mg 2.98 ± 6.89 3.49 ± 8.18 1.76 ± 0.29 >0.05
SGOT 67.05 ± 49.72 61.00 ± 13.38 81.67 ± 90.58 >0.05
SGPT 40.73 ± 22.92 37.00 ± 10.33 49.75 ± 38.91 >0.05
Albumin 3.41 ± 0.78 3.47 ± 0.90 3.27 ± 0.40 >0.05
Serum creatinine 1.13 ± 0.55 0.93 ± 0.40 1.59 ± 0.61 <0.001**
WBC 16.22 ± 6.18 15.90 ± 6.41 16.99 ± 5.77 >0.05
RBC 4.74 ± 0.97 4.63 ± 0.69 5.02 ± 1.45 >0.05
HB 12.87 ± 1.34 13.05 ± 1.13 12.45 ± 1.73 >0.05
HCT 38.49 ± 4.72 39.383.42 36.33 ± 6.65 >0.05
Platelets 409.95 ± 193.56 427.97 ± 179.15 366.42 ± 227.21 >0.05
INR 1.69 ± 0.79 1.52 ± 0.57 2.08 ± 1.11 >0.05
PTT 28.40 ± 6.52 27.07 ± 4.57 31.60 ± 9.24 <0.05*
CRP 221.15 ± 93.32 252.55 ± 75.05 145.25 ± 91.90 <0.001**
ESR 78.37 ± 28.40 73.00 ± 31.75 91.33 ± 10.32 >0.05
CVP 11.98 ± 5.52 11.62 ± 3.80 12.83 ± 8.54 >0.05
Fluid balance/week 524.60 ± 5624.77 2178.25 ± 3345.04 7056.50 ± 4556.48 <0.001**
GCS 10.07 ± 4.40 12.45 ± 2.50 4.33 ± 1.92 <0.001**
Chest X-ray (no of quarter opacities) 3.51 ± 0.78 3.41.82 3.75.62 >0.05
CT Rt. lung (lobes aﬀected) 6.29 ± 1.17 6.34 ± 1.11 6.17 ± 1.34 >0.05
CT Lt. lung (lobes aﬀected) 5.32 ± 1.59 5.07 ± 1.60 5.92 ± 1.44 >0.05
CT total lobes aﬀected 11.61 ± 2.02 11.41 ± 1.92 12.08 ± 2.27 >0.05
Abnormal ECHO no (%) 14 (34.10%) 10 (34.5%) 4 (33.3%) >0.05
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Table 3 Validation of some selected parameters in the prediction of survival among the studied ARDS patients.
Cutoﬀ point Area under the curve (95% CI) Sensitivity (%) Speciﬁcity (%)
Predictors of non-survival
Fluid balance/week 2694.63 0.907 (0.831–0.982) 91.70 93.10
Duration of illness before ICU admission (days) 6.5 0.894 (0.823–0.964) 100.00 82.80
Serum creatinine (mg %) 1.15 0.958 (0.912–1.000) 100.00 93.10
Predictors of survival
GCS total 9 0.976 (0.948–1.000) 93.7 100.00
PaO2/FiO2 90.08 0.853 (0.739–0.968) 93.10 83.30
Fig. 1 ROC curve shows the accuracy of GCS and PaO2 in the prediction of survival of the studied ARDS patients.
Fig. 2 ROC curve shows the accuracy of ﬂuid balance per week, duration of illness before ICU admission, and serum creatinine level in
the prediction of non-survival of the studied ARDS patients.
Outcome improvement predictors in acute respiratory distress syndrome patients 999
1000 A.M. Saleh et al.therapy shown to have a mortality beneﬁt is lung protective
ventilation [6]. Similarly, observational studies of ALI/ARDS
performed at the University of California San Francisco
Hospital System over the past 15 years have also shown a
decline in mortality. In the early 1990s, Doyle et al. [4]
reported a hospital mortality rate of 58% for patients with
ALI/ARDS, whereas by the late 1990s, Nuckton et al. [5]
found that the mortality rate of patients with ARDS alone
was 42%. In the current study of patients with ALI/ARDS,
the mortality rate was 41%. In another observational study
where the ARDS Net protocol was more strictly adhered to,
as evidenced by an average Vt of 6.2 ml/kg of the predicted
body weight (PBW) that was maintained over the ﬁrst week
of ALI/ARDS, the hospital mortality rate was 32% despite
the presence of some of the same comorbid conditions as those
found in the present study [15].
This ﬁnding suggests the possibility that relatively higher
mortality rate, despite the intention to use lung protective
ventilation, may be a result of delayed recognition of ARDS
or less rigorous adherence to the ARDS Net goal of a Vt of
6 ml/kg PBW. This suggestion is strongly supported by the
ﬁnding of our study that delayed ICU admission was a signif-
icant factor in the non-surviving patients.
Recently, a New Berlin deﬁnition of ARDS [8] has been
proposed, and it is endorsed by the European Society of Inten-
sive Care Medicine, the American Thoracic Society (ATS), and
the Society of Critical Care Medicine (SCCM). According to
this new deﬁnition, three ARDS categories were developed
on the basis of hypoxemia with a PEEP setting of 5+: mild
(PaO2/FiO2 6300 mmHg but >200 mmHg), moderate
(PaO2/FiO2 6200 mmHg but >100 mmHg), and severe
(PaO2/FiO2 6100 mmHg). These groups, according to the
consensus panel, were associated with increased mortality
(27%, 32%, and 45%, respectively). In the present study, only
moderate and severe ARDS patients were included; therefore,
the mortality rate of less than 30% is more improved than the
stated range in the Berlin deﬁnition of ARDS. As we recruited
patients on the basis of the new deﬁnition, the sample size was
small; because of the small sample size, only univariate analy-
sis was possible, and we cannot calculate the independent risk
factor of mortality using a multivariate analysis. However, we
used receiver operating characteristic (ROC) curves to evaluate
the accuracy of some of the factors affecting survival.
In recent years, there has been an increasing interest world-
wide to determine the individual predictors of mortality in
ARDS. Moreover, we found 25 signiﬁcant predictors of mor-
tality that can help improve prognosis evaluation within the
ﬁrst 24 h of admission.
We found that approximately 25 predictors of mortality
were signiﬁcantly different in the non-surviving patients based
on the patient demographic data and the clinical and labora-
tory data; the non-surviving patients were older, were more
likely to be smokers, had more prolonged durations of illness
before ICU admission and more prolonged ICU admissions;
and had higher frequencies of co-morbidities with DM, hyper-
tension, and cardiac problems.
Important and simple predictors were suggested by this
study. On admission to the ICU, the non-surviving patients’
vital signs revealed tachypnea, tachycardia, and lower DBP
compared with the patients who survived.
Additionally, based on the arterial blood gases, the non-
surviving patients had lower PaO2/FiO2, PO2, O2sat, andHCO3 values and higher PCO2 values; therefore, they required
a higher FiO2. These results are consistent with an observa-
tional study of 3670 patients with ARDS which found that
patients with mild (PaO2/FiO2 >200 but 6300 mmHg),
moderate (PaO2/FiO2 >100 but 6200 mmHg), or severe
(A PaO2/FiO2 of 6100 mmHg) ARDS had increased mortality
rates with increased disease severity [7].
Similarly, there is a general agreement that improvement of
oxygenation during the early ICU course is correlated with
survival [16].
Additionally, the non-surviving patients had lower Na
levels, higher K levels, and higher acidotic pH and creatinine
levels compared with the surviving patients. CRP and GCS
were signiﬁcantly lower in the non-surviving patients.
Additionally and importantly, the average weekly ﬂuid
balance in the non-surviving patients was positive and signiﬁ-
cantly higher than that in the patients who survived, who had a
negative ﬂuid balance. This ﬁnding and, therefore, the pro-
posed therapeutic approach is supported and is consistent with
a report by Sakr et al. in 2005 which showed that a positive
ﬂuid balance may be associated with higher mortality; in
addition, the ARDSNet trial reported that a negative ﬂuid
balance on the day 4 was associated with decreased mortality
compared with a positive ﬂuid balance [17].
The additional therapeutic approach that has improved
clinical outcomes in ARDS is the use of a conservative ﬂuid
strategy once shock has been resolved. Based on experimental
studies, a reduction in the lung vascular hydrostatic pressure
decreases the pulmonary edema in the setting of increased lung
vascular permeability [18]. The NHLBI ARDS Network trial
of 1000 patients reported that a conservative ﬂuid strategy
signiﬁcantly reduced the average duration of mechanical
ventilation by 2.5 days [17].
Finally, 4 non-surviving patients (33.3%) developed posi-
tive blood C/S HAP, whereas none of the surviving patients
did. Other respiratory, hemodynamic, laboratory and radio-
logical parameters were not signiﬁcantly different between
the two groups.
Conclusions
The ARDS mortality rate was improved after the implementa-
tion of the lung protective ventilation strategy. Early diagnosis
and ICU admission, a PaO2/FiO2 ratio above 90, a GCS above
9, a negative ﬂuid balance, and a serum creatinine level less
than 1.5 mg/dl, in addition to the prevention of HAP, were
outcome-improving factors in ARDS.Conﬂict of interest
We have no conﬂict of interest and no ﬁnancial support.
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